Interview with Fabio Garofolo (Algorithme Pharma) on anti-body drug conjugates (ADCs) and the EBF 7th Open Symposium

Written by Cameron Low, Future Science Group

In this interview Fabio Garofolo provides insight into various challenging aspects of anti-body drug conjugates (ADCs). Fabio also provides details of his novel approach for total ADC quantification and discusses which talk he particularly enjoyed at the EBF 7th Open Symposium.